Harmen Beurmanjer

110 References Galloway, G. P., Frederick, S. L., & Staggers, F. (1994). Physical dependence on sodium oxybate. The Lancet , Vol. 343, p. 57. https://doi.org/10.1016/S0140-6736 (94)90911-3 Galloway, G. P., Frederick, S. L., Staggers, F. E., Gonzales, M., Stalcup, S. A., & Smith, D. E. (1997). Gamma-hydroxybutyr- ate: An emerging drug of abuse that causes physical dependence. Addiction , 92 (1), 89–96. https://doi. org/10.1111/j.1360-0443.1997.tb03640.x Garcia, A. N., & Salloum, I. M. (2015). Polysomnographic sleep disturbances in nicotine, caffeine, alcohol, cocaine, opioid, and cannabis use: A focused review. American Journal on Addictions . https://doi.org/10.1111/ajad.12291 Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory. International Journal of Qualitative Methods , 5 , 1–10. https://doi.org/10.2307/588533 Gonzalez, A., & Nutt, D. J. (2005). Gamma hydroxy butyrate abuse and dependency. Journal of Psychopharmacology , 19 (2), 195–204. https://doi.org/10.1177/0269881105049041 Groleau, D., Young, A., & Kirmayer, L. J. (2006). The McGill Illness Narrative Interview (MINI): An Interview Schedule to Elicit Meanings and Modes of Reasoning Related to Illness Experience. Transcultural Psychiatry , 43 (4), 671–691. https://doi.org/10.1177/1363461506070796 Grund, J. P., de Bruin, D., & van Gaalen, S. (2018). Going knock—Recurrent comatose GHB intoxication in the Netherlands & Flanders (Belgium). International Journal of Drug Policy , 58 , 137–148. https://doi.org/10.1016/j. drugpo.2018.06.010 Ha, J., Yoon, E., Kim, J., Hwang, M., Jang, J., Kim, Y., … Kim, K. (2009). Risk assessment study of GHB and its precursors (GBL, 1,4-BD) in South Korea. Drug Safety , 32 (10) , 917. https://doi.org/http: / /dx.doi.org/10.2165/11316660- 000000000-00000 Habibian, S., Ahamad, K., McLean, M., & Socias, M. E. (2019). Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy. Journal of Addiction Medicine , 1. https://doi. org/10.1097/adm.0000000000000514 Hagger, M. S., & Orbell, S. (2003). A meta-analytic review of the common-sense model of illness representations. Psychology and Health , Vol. 18, pp. 141–184. https://doi.org/10.1080/088704403100081321 Handelsman, L., Cochrane, K. J., Aronson, M. J., Ness, R., Rubinstein, K. J., & Kanof, P. D. (1987). Two new rating scales for opiate withdrawal. American Journal of Drug and Alcohol Abuse , 13 (3), 293–308. https://doi.org/10.3109/ 00952998709001515 Harris, K., Harburg, G. R., & Isoardi, K. Z. (2020). When fantasy fades: A case of severe delirium due to GHB withdrawal. EMA - Emergency Medicine Australasia . https://doi.org/10.1111/1742-6723.13449 Johansson, J., Grönbladh, A., & Hallberg, M. (2014). Gamma-hydroxybutyrate (GHB) induces cognitive deficits and affects GABAB receptors and IGF-1 receptors in male rats. Behavioural Brain Research , 269 , 164–174. https://doi. org/10.1016/j.bbr.2014.04.034 Jones, C. J., Smith, H. E., & Llewellyn, C. D. (2016). A systematic review of the effectiveness of interventions using the Common Sense Self-Regulatory Model to improve adherence behaviours. Journal of Health Psychology , 21 (11), 2709–2724. https://doi.org/10.1177/1359105315583372 Joosten, E., Van Wamel, A., Beurmanjer, H., & Dijkstr, B. (2020). Handreiking voor GHB behandeling . Nijmegen. Kamal, R. M., Dijkstra, B. A. G., Loonen, A. J., & De Jong, C. A. J. (2016). The effect of co-occurring substance use on gamma-hydroxybutyric acid withdrawal syndrome. Journal of Addiction Medicine , 10 (4), 229–235. https://doi. org/10.1097/ADM.0000000000000214 Kamal, R. M., Loonen, A. J. M., Dijkstra, B. A. G., & De Jong, C. A. J. (2015). Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate dependence. Journal of Clinical Kamal, R. M., Schellekens, A., De Jong, C. A. J., & Dijkstra, B. A. G. (2015). Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: An open label study. BMC Psychiatry , 15 (1), 1–8. https://doi. org/10.1186/s12888-015-0471-4 Kamal, R. M., van Iwaarden, S., Dijkstra, B. A. G., & de Jong, C. A. J. (2014). Decision rules for GHB (gamma-hydroxybu- tyric acid) detoxification: A vignette study. Drug and Alcohol Dependence , 135 (1), 146–151. https://doi. org/10.1016/j.drugalcdep.2013.12.003 Kamal, R. M., van Noorden, M. S., Wannet, W., Beurmanjer, H., Dijkstra, B. A. G., & Schellekens, A. (2017). Pharmacolog- ical Treatment in gamma-Hydroxybutyrate (GHB) and gamma-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs , 31 (1), 51–64. https://doi.org/10.1007/s40263-016-0402-z